trial
as of 2026-07-01rTMS as a Probe of Episodic Memory Neurocircuitry in Schizophrenia
NCTId NCT04182113
at a glance
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
25 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Quadruple
Start
2019-11-08
Primary completion
2022-06-30
Eligibility
ALL · 18 Years · 40 Years
Interventions & indications
Sponsors
Indiana UniversityLead Sponsor
Investigators
1
Tom Hummer, PhDPrincipal Investigator
Sites
2 total
Indianapolis, United StatesIndianapolis, United States
Facts & assertions
4 sourced
Enrollment
25
Phase
NA
Primary Completion Date
2022-06-30
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
company
indication
investigator
person